Moertel Cg
Impact in
- Oncology top 5%
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
-
- Gastric Cancer Management and Outcomes
Papers in
- Oncology 33
- Colorectal Cancer Treatments and Studies 28
- Pancreatic and Hepatic Oncology Research 2
- Colorectal Cancer Surgical Treatments 2
- Cancer Treatment and Pharmacology 1
-
- Neuroendocrine Tumor Research Advances 4
- Co-authors
- Robert G. Hahn (25 shared papers)Richard J. Reitemeier (22 shared papers)Allan J. Schutt (24 shared papers)Pemberton Jh (1 shared paper)Susan Galandiuk (1 shared paper)H. Sam Wieand (1 shared paper)Bruce G. Wolff (1 shared paper)Fitzgibbons Rj (1 shared paper)
- Journals
- PubMed (52 papers)
- Partner nations
- United States
In The Last Decade
Moertel Cg
50 papers receiving 960 citations
Peers
Comparison fields: 5 of 44
- Oncology 386
- Pulmonary and Respiratory Medicine 112
- Epidemiology 112
- Toxicology 10
- Radiology, Nuclear Medicine and Imaging 38
Countries citing papers authored by Moertel Cg
This map shows the geographic impact of Moertel Cg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moertel Cg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moertel Cg more than expected).
Fields of papers citing papers by Moertel Cg
This network shows the impact of papers produced by Moertel Cg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moertel Cg. The network helps show where Moertel Cg may publish in the future.
Co-authors
The 25 scholars most cited alongside Moertel Cg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Patterns of recurrence after curative resection of carcinoma of the colon and rectum. | 1992 | 382 |
| 2 | Phase II study of cis-diamminedichloroplatinum (NSC-119875) in advanced carcinoma of the large bowel. | 1974 | 53 |
| 3 | Phase II trial of doxorubicin therapy for advanced islet cell carcinoma. | 1982 | 52 |
| 4 | Therapy of advanced gastrointestinal cancer with the nitrosoureas. | 1973 | 48 |
| 5 | CEREBELLAR ATAXIA ASSOCIATED WITH FLUORINATED PYRIMIDINE THERAPY. | 1964 | 46 |
| 6 | Treatment of metastatic carcinoid tumor with dactinomycin or dacarbazine. | 1983 | 45 |
| 7 | Phase II-III chemotherapy studies in advanced gastric cancer. Eastern Cooperative Oncology Group. | 1980 | 44 |
| 8 | Therapy for gastrointestinal cancer with the nitrosoureas alone and in drug combination. | 1976 | 31 |
| 9 | Pharmacokinetics of mitomycin C in patients receiving the drug alone or in combination. | 1983 | 31 |
| 10 | Phase II study of cisplatin therapy in patients with metastatic carcinoid tumor and the malignant carcinoid syndrome. | 1986 | 31 |
| 11 | Metabolic studies of delta-9-tetrahydrocannabinol in cancer patients. | 1984 | 28 |
| 12 | Chemotherapy of gastric and pancreatic carcinoma: a controlled evaluation of combinations of 5-fluorouracil with nitrosoureas and "lactones". | 1979 | 27 |
| 13 | Treatment of advanced squamous cell carcinoma of the gastrointestinal tract with bleomycin (NSC-125066). | 1974 | 26 |
| 14 | Phase II study of 5-azacytidine (NSC-102816) in the treatment of advanced gastrointestinal cancer. | 1972 | 24 |
| 15 | Phase II study of ICRF-159 (NSC-129943) in advanced colorectal carcinoma. | 1975 | 23 |
| 16 | The natural history of advanced gastric cancer. | 1968 | 22 |
| 17 | Effects of patient selection on results of phase II chemotherapy trials in gastrointestinal cancer. | 1974 | 22 |
| 18 | Phase II studies of dianhydrogalactitol and VP-16-213 in colorectal cancer. | 1976 | 20 |
| 19 | Comparison of rapid and slow intravenous administration of 5-fluorouracil in treating patients with advanced carcinoma of the large intestine. | 1962 | 18 |
| 20 | Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer. | 1976 | 18 |
About Moertel Cg
Moertel Cg is a scholar working on Oncology, Epidemiology, Pulmonary and Respiratory Medicine, Pharmacology and Immunology, having authored 52 papers that have together received 1.2k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (28 papers), Neuroendocrine Tumor Research Advances (4 papers), Gastric Cancer Management and Outcomes (3 papers), Pancreatic and Hepatic Oncology Research (2 papers), Colorectal Cancer Surgical Treatments (2 papers), Cancer Treatment and Pharmacology (1 paper), Cannabis and Cannabinoid Research (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Oncology (386 citations), Pulmonary and Respiratory Medicine (112 citations), Epidemiology (112 citations), Toxicology (10 citations) and Radiology, Nuclear Medicine and Imaging (38 citations). Moertel Cg has collaborated with scholars based in United States. Frequent co-authors include Robert G. Hahn, Richard J. Reitemeier, Allan J. Schutt, Pemberton Jh, Susan Galandiuk, H. Sam Wieand, Bruce G. Wolff, Fitzgibbons Rj, Philip T. Lavin and O'Connell Mj. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.